| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $1,601,839 | 4 | 44 |
Sells | $28,859,274 | 5 | 56 |
| HALBERT JON | director | 1 | $990,080 | 0 | $0 | $990,080 |
| Vacirca Jeff L | director | 1 | $501,426 | 0 | $0 | $501,426 |
| Denton John Russel | See Remarks | 1 | $100,793 | 1 | $238,626 | $-137,833 |
| Spetzler David Baxley | President | 1 | $9,540 | 2 | $14.83M | $-14.82M |
| Power Luke Thomas | See Remarks | 0 | $0 | 1 | $1.65M | $-1.65M |
| Brille Brian J | See Remarks | 0 | $0 | 1 | $12.13M | $-12.13M |
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a …
Over the last 12 months, insiders at Caris Life Sciences, Inc. have bought $1.6M and sold $28.86M worth of Caris Life Sciences, Inc. stock.
On average, over the past 5 years, insiders at Caris Life Sciences, Inc. have bought $1.6M and sold $28.86M worth of stock each year.
Highest buying activity among insiders over the last 12 months: HALBERT JON (director) — $990,080. Vacirca Jeff L (director) — $501,426. Denton John Russel (See Remarks) — $100,793.
The last purchase of 68,000 shares for transaction amount of $990,080 was made by HALBERT JON (director) on 2026‑05‑15.
| 2026-09-22 | Sale | Denton John Russel | See Remarks | 7,500 0.0028% | $31.82 | $238,626 | +0.41% | |
| 2026-09-17 | Sale | Brille Brian J | See Remarks | 400,000 0.1388% | $30.33 | $12.13M | +1.78% | |
| 2026-09-04 | Sale | Spetzler David Baxley | President | 119,212 0.0416% | $24.76 | $2.95M | +22.26% | |
| 2026-09-03 | Sale | Spetzler David Baxley | President | 478,000 0.166% | $24.86 | $11.88M | +21.01% | |
| 2026-05-15 | HALBERT JON | director | 68,000 0.0241% | $14.56 | $990,080 | +51.13% | ||
| 2026-05-11 | Vacirca Jeff L | director | 31,050 0.0111% | $16.15 | $501,426 | +33.63% | ||
| 2025-12-11 | Sale | Power Luke Thomas | See Remarks | 62,250 0.0204% | $26.58 | $1.65M | -22.25% | |
| 2025-11-07 | Spetzler David Baxley | President | 400 0.0001% | $23.85 | $9,540 | -16.05% | ||
| 2025-11-07 | Denton John Russel | See Remarks | 4,184 0.0012% | $24.09 | $100,793 | -16.05% | ||
| 2019-03-29 | Sale | Sawka Gary | director | 10,000 0.0029% | $23.23 | $232,300 | ||
| 2019-02-27 | Garcia Victor | President and CEO | 100 <0.0001% | $22.74 | $2,274 | |||
| 2019-02-26 | Garcia Victor | President and CEO | 10,508 0.0029% | $22.24 | $233,698 | |||
| 2018-06-01 | Garcia Victor | President and CEO | 10,000 0.003% | $24.25 | $242,480 | |||
| 2018-05-14 | Garcia Victor | President and CEO | 2,079 – | $25.00 | $51,975 | |||
| 2018-05-11 | Garcia Victor | President and CEO | 9,921 – | $25.00 | $248,025 | |||
| 2018-05-01 | Sale | Ogawa Family Trust | 10 percent owner | 1.23M 0.3453% | $22.81 | $27.95M | ||
| 2018-05-01 | Sale | Ogawa Andrew | 1.23M 0.3453% | $22.81 | $27.95M | |||
| 2018-02-20 | Sale | Ogawa Family Trust | 10 percent owner | 1.25M 0.3333% | $21.58 | $26.98M | ||
| 2017-12-07 | Sale | REMINGTON DAVID G | director | 4,360 0.0018% | $33.10 | $144,316 | ||
| 2017-12-06 | Sale | REMINGTON DAVID G | director | 3,200 0.0013% | $31.91 | $102,112 |
| Increased Positions | 140 | +106.06% | 53M | +46.57% |
| Decreased Positions | 58 | -43.94% | 20M | -17.45% |
| New Positions | 76 | New | 27M | New |
| Sold Out Positions | 27 | Sold Out | 9M | Sold Out |
| Total Postitions | 214 | +62.12% | 146M | +29.12% |